Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Purite vs Dorzolamide Adjunctive to Latanoprost in Glaucoma
NCT00348400Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of brimonidine purite in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Intraocular Pressure at 6 months. Status: completed.
02
Drugs
brimonidine purite
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00348400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348400.